2Mennink-KerstenMA, Dormelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis [J]. lancet Infect Dis, 2004, 4 (6) : 349 - 357.
3Pazos C, Ponton J, Del Palocio A. Contribution of (1, 3) -β-D- glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neurpenic adult patients: a comparison with serial screening for circulating galactomannan [J]. J Clin Microbiol, 2005, 43 (1): 299-305.
4Odabasi Z, Mattiuzzi G, Estey E, et al. β-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome [J]. Clin Infect Dis, 2004, 39 (2): 199-205.
5Yoshida K. Recent advances of serodiagnosis for systemic fungal infections [J]. Nippon lshinkin Gakkai Zasshi, 2006, 47 (3) : 135-142.
6Kedzierska A. ( 1, 3) -beta-D-glucan-a new marker for the early serodiagnosis of deep-seated fungal infections in humans [J]. Pol J Microbiol, 2007, 56 (1): 3-9.
7Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis [J ]. Lancet Infect Dis, 2004, 4 ( 6 ) :349-357.
8Pazos C, Ponton J, Del Palacio A. Contribution of (1,3)-β-D- glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neurpenic adult patients: a comparison with serial screening for circulating galactomannan[J]. J Clin Microbiol, 2005, 43(1):299 305.
9Odabasi Z, Mattiuzzi G, Estey E,et al. β-D-gluean as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome[J]. Clin Infect Dis, 2004,39 (2), 199-205.
10Yoshida K. Recent advances of serodiagnosis for systemic fungal infections[J]. Nippon lshinkin Gakkai Zasshi, 2006, 47 ( 3 ) :135- 142.
